"Designing Growth Strategies is in our DNA"

Neurodegenerative Diseases Drugs Market Size, Share and Industry Analysis By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), Others), By Route of Administration (Oral, Injection, Transdermal, Others), By End User and Regional Forecast 2019-2026

Region : Global | Format: PDF | Report ID: FBI100661

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Final report will be updated to address the impact of COVID-19 on this particular market

Request a Sample

Refresh Button
Booklet
  • Jun, 2019
  • 2018
  • 2015-2017
  • 166

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X